Atossa Genetics Inc (ATOS)
US$ 0.99-4.81%
Price Chart
Key Statistics
Market Cap
$ 116.27M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
1.46M
52W High
$ 1.66
52W Low
$ 0.55
Dividend Yield
0.00%
Beta
0.90
Technicals
50-Day MA
0.7758
200-Day MA
1.0485
52 Week High
1.66
52 Week Low
0.5526
About ATOS
Atossa Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops medicines in the areas of unmet medical need in oncology for women breast cancer and other conditions in .
Employees
15
Headquarters
Seattle, WA
CEO
Dr. Steven C. Quay FCAP, M.D., Ph.D.
Latest News
French state makes offer to buy part of Atos' former Advanced Computing unit - Reuters
5 days ago • Google News
Good news for Atos: Advanced Computing sold to France - techzine.eu
5 days ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg